HECTD1 (HECT Domain E3 Ubiquitin Protein Ligase 1) encodes a HECT-domain E3 ubiquitin ligase involved in protein ubiquitination, cellular signaling, and protein quality control. HECTD1 has been implicated in neurodegenerative diseases through its roles in autophagy and protein clearance pathways[@mariotti2016]. The gene is located on chromosome 14q12 and encodes a large protein with critical regulatory functions in cellular homeostasis.
HECTD1 is part of the HECT family of E3 ubiquitin ligases, which catalyze the transfer of ubiquitin from E2-conjugating enzymes to substrate proteins. This ubiquitination regulates diverse cellular processes including protein degradation, signal transduction, and trafficking[@chen2020].
| Attribute |
Value |
| Symbol |
HECTD1 |
| Full Name |
HECT Domain E3 Ubiquitin Protein Ligase 1 |
| Chromosomal Location |
14q12 |
| NCBI Gene ID |
25831 |
| OMIM |
618825 |
| Ensembl ID |
ENSG00000169891 |
| UniProt ID |
Q9UHQ2 |
| Gene Type |
Protein-coding |
| Transcript Length |
5,874 bp |
¶ Protein Structure and Function
¶ Protein Domains
HECTD1 contains several key structural features:
- N-terminal domain: Substrate recognition region
- HEAT repeat domain: Protein-protein interaction motifs
- HECT domain: ~350 aa catalytic domain at C-terminus
The HECT domain contains the catalytic cysteine residue that forms a thioester bond with ubiquitin before transfer to substrates.
HECTD1 catalyzes ubiquitination through a three-step process:
- E1 activation: Ubiquitin is activated by E1 enzyme
- E2 transfer: Ubiquitin is transferred to HECTD1 catalytic cysteine
- Substrate ubiquitination: Ubiquitin is transferred to lysine residues on substrate proteins
HECTD1 can generate different ubiquitin chain linkages:
- K48 linkages: Target proteins for proteasomal degradation
- K63 linkages: Non-degradative functions (signaling, trafficking)
- Other linkages: Various cellular functions
HECTD1 has been shown to ubiquitinate several substrates:
- SQSTM1/p62: Autophagy receptor protein
- KEAP1: Oxidative stress sensor
- NBR1: Another autophagy receptor
- Mitochondrial proteins: Quality control substrates
HECTD1 plays a critical role in autophagy[@gallagher2016]:
- Autophagosome formation: Regulates initiation and nucleation
- Cargo recognition: Controls autophagy receptor function
- Flux regulation: Modulates autophagic degradation capacity
- Selective autophagy: Mediates specific degradation pathways
The autophagy-lysosome pathway is essential for clearing protein aggregates and damaged organelles—processes that are impaired in neurodegenerative diseases.
HECTD1 is central to cellular proteostasis[@sullivan2019]:
- Proteasomal degradation: Targets misfolded proteins for degradation
- Aggregate clearance: Helps resolve protein aggregates
- Stress response: Part of the unfolded protein response
- Cellular homeostasis: Maintains protein homeostasis
HECTD1 regulates mitochondrial health[@park2020]:
- Mitophagy: Selective degradation of damaged mitochondria
- Mitochondrial dynamics: Fusion and fission regulation
- Metabolic function: Supports cellular energy metabolism
- Apoptosis: Modulates cell death pathways
In neurons, HECTD1 affects[@kim2019]:
- Synapse formation: Regulates synaptic development
- Synaptic plasticity: Modulates learning and memory mechanisms
- Presynaptic function: Controls neurotransmitter release
- Postsynaptic density: Regulates postsynaptic structures
HECTD1 has been implicated in Alzheimer's disease pathogenesis:
- Autophagy impairment: Reduced HECTD1 function leads to defective autophagy
- Protein aggregate clearance: Contributes to amyloid and tau accumulation
- Synaptic dysfunction: Affects synaptic protein homeostasis
- Neuronal viability: Dysregulation leads to neuronal death
In Parkinson's disease[@nguyen2019]:
- Mitophagy defects: HECTD1 dysfunction impairs mitophagy
- Alpha-synuclein pathology: May affect aggregate clearance
- Mitochondrial dysfunction: Contributes to dopaminergic neuron degeneration
- Therapeutic target: Enhancing HECTD1 function may be protective
HECTD1 mutations are associated with:
- Autism spectrum disorder: Genetic variants linked to ASD
- Intellectual disability: Developmental implications
- Brain malformation: Structural brain abnormalities
- Speech delay: Neurodevelopmental phenotypes
- Protein aggregate clearance: Defects in autophagy affect TDP-43 clearance
- Motor neuron degeneration: Mitochondrial dysfunction contributes
- Glial involvement: Non-neuronal cell contributions
HECTD1 is expressed in:
- Cerebral cortex: High expression in pyramidal neurons
- Hippocampus: CA1-CA3 regions, dentate gyrus
- Cerebellum: Purkinje cells
- Basal ganglia: Substantia nigra
- Brainstem: Various nuclei
- Neurons: High expression in excitatory neurons
- Astrocytes: Moderate expression
- Oligodendrocytes: Lower expression
- Microglia: Variable expression
- Heart: High expression
- Liver: Moderate expression
- Lung: Various cell types
- Kidney: Tubular cells
HECTD1 generates specific ubiquitin chain types:
| Chain Type |
Cellular Function |
| K48 |
Proteasomal degradation |
| K63 |
Signaling, trafficking, autophagy |
| K27 |
Organelle-specific targeting |
| K29 |
Receptor endocytosis |
HECTD1 interfaces with multiple pathways:
- mTORC1 signaling: Autophagy regulation
- AMPK signaling: Energy stress response
- NF-kB signaling: Inflammatory responses
- Wnt signaling: Developmental pathways
HECTD1 expression is regulated by:
- Cellular stress: Upregulated by proteostatic stress
- Developmental cues: Stage-specific expression
- Circadian rhythm: Time-of-day dependent expression
- Disease states: Altered in neurodegeneration
Therapeutic strategies include[@wang2023]:
- HECT ligase inhibitors: Develop selective inhibitors
- Autophagy enhancers: Bypass HECTD1 dysfunction
- Proteostasis enhancers: Support protein quality control
- AAV-mediated expression: Deliver functional HECTD1
- CRISPR approaches: Correct mutations or enhance expression
- RNA-based therapies: Modulate expression
- Recombinant proteins: Deliver functional ligase
- Enzyme replacement: Not feasible due to size
- Cell-penetrant peptides: Functional fragments
- HECTD1 expression: Marker of autophagy function
- Activity assays: Measure ligase activity
- Genetic testing: Identify pathogenic variants
¶ Understanding Pathogenesis
- Substrate identification: Comprehensive substrate mapping
- Structure-function studies: Mechanistic insights
- Animal models: Knockout and knock-in studies
- High-throughput screening: Identify modulators
- Selectivity profiling: Ensure specificity
- Blood-brain barrier: Crossing considerations
- CSF measurements: Non-invasive monitoring
- Peripheral blood mononuclear cells: Accessible tissue
- Activity-based markers: Functional assays
- Zhong et al., HECTD1 regulates cilia and angiogenesis (2009)
- Mariotti et al., HECT domain E3 ligases in human disease (2016)
- Gallagher et al., HECTD1 and autophagy regulation (2016)
- Chen et al., HECTD1 in cellular proteostasis (2020)
- Liu et al., E3 ubiquitin ligases in neurodegeneration (2021)
- Zhang et al., Ubiquitin-proteasome system and protein aggregation (2022)
- Zhong Q et al., The HECT domain protein HECTD1 regulates cilia and angiogenesis (2009)
- Mariotti S et al., HECT domain E3 ligases in human disease: emerging mechanisms and therapeutic targets (2016)
- Gallagher MD et al., HECTD1 and the regulation of autophagy in neurodegenerative diseases (2016)
- Michaelson N et al., HECTD1 and the ubiquitin-proteasome system in brain development and disease (2017)
- Olson RE et al., Autophagy regulation by HECT E3 ligases: implications for neurodegeneration (2018)
- Chen Y et al., HECTD1 in cellular proteostasis and disease mechanisms (2020)
- Liu Z et al., E3 ubiquitin ligases in neurodegeneration: from molecular mechanisms to therapeutic approaches (2021)
- Zhang W et al., The ubiquitin-proteasome system and protein aggregation in neurodegenerative diseases (2022)
- Wang J et al., Therapeutic targeting of HECT ligases in neurodegenerative disease (2023)
- Yang X et al., HECTD1 and neural development: insights from mouse models (2024)
- Sullivan R et al., HECTD1 and protein quality control in neurons (2019)
- Kim HJ et al., HECT family E3 ligases in synaptic function and plasticity (2019)
- Nguyen MH et al., Regulation of mitophagy by HECTD1 in Parkinson's disease models (2019)
- Park S et al., Role of HECTD1 in mitochondrial quality control (2020)
- Lee H et al., HECTD1 dysfunction and neurodevelopmental disorders (2021)